A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Maastricht University Medical Center
Leap Therapeutics, Inc.
Fate Therapeutics
EMD Serono
Pfizer